Vanderbilt TB Center News

Successful Semi Annual Meeting of RePORT-Brazil

The Regional Prospective Observational Research for Tuberculosis (RePORT) - Brazil Semi Annual Meeting was held October 17th through October 21st in Salvador, Bahia. Investigators and staff from throughout the network participated in a variety of workshops, presentations, and collaborative planning sessions, both in-person and from remote locations. 

VUMC lands Grant to build top-line Biosafety Facility

Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. When the renovation of about 3,500 square feet of existing space is completed, the facility will include three BSL3 suites with separate entrances and seven procedure rooms capable of securely containing multiple organisms at the second-highest biosafety level.

VUMC investigators attend RePORT-International Annual Meeting

VUMC investigators and staff, Timothy Sterling, Yuri van der Heijden, Stephany Duda, Marina Figueiredo, Fernanda Mauri, Megan Turner, and Austin Katona; attended the annual RePORT International meeting that was held in Cape Town, South Africa, September 7 and 8, 2022. The meeting included all seven regions of RePORT: Brazil, China, South Africa, South Korea, India, Indonesia, and the Philippines. It was a successful meeting full of presentations and collaborative discussions.

Leonardo Barreto's work in the Sterling Lab investigating MIC in Mtb isolates

Leonardo Barreto, Public Health Technologist at Instituto Nacional de Infectologia Evandro Chagas – FIOCRUZ, has spent the last 6 months in the Sterling Lab evaluating subtle changes in drug resistance (Minimum Inhibitory Concentration - MIC) in M. tuberculosis isolates from study participants from the NIH-funded project “Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis” (R01AI120790).

Nancy Séraphin, MPH, PhD visits Vanderbilt TB Center

Nancy Séraphin, MPH, PhD, Research Assistant Professor in the Department of Medicine, Division of Infectious Diseases and Global Medicine (IDGM), and the Emerging Pathogens Institute (EPI) at the University of Florida visited VUMC between June 13th-15th. Her visit was highlighted by meetings with the TB Center team, collaborative discussions with researchers at VUMC, and the presentation of a guest lecture entitled: "The public health importance of Mycobacterium tuberculosis intra-host genetic variability”.

VTC hosts visitors from Brazil, South Africa, UW for grant project meeting

Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between May 31st and June 2nd, included presentations about ongoing research and initial data, working group sessions, and breakout meetings.

WHO Global TB Report was released!

Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.